Stocks
Asensus Surgical (ASXC) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | ||||
| EBITDA margin, % | ? | -899.6% | -895.2% | -867.4% | -867.4% | -442.4% | |||
| Changes by years, y/y, % | +595pp | +4pp | +28pp | 0pp | +33.9% | ||||
Asensus Surgical. EBITDA margin, %
Asensus Surgical. EBITDA margin, changes, pp
Asensus Surgical (ASXC) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA margin, % | ? | -1 816% | -264.2% | -264.2% | -1 532% | -765.3% | -442.4% | |
| Changes by years, y/y, % | -1 191pp | +346pp | +346pp | +630pp | +1 040pp | |||
| Changes by quarters, q/q, % | -11pp | +1 552pp | 0pp | -1 267pp | +766pp | |||
